"Global cannabis stocks are plunging as investors shift from upstream to downstream markets."
Told you AusCann had a sound business model. They know what's up. Google and read this article. Practically everything a medical cannabis company requires to do to be most successful is being done so by the board of AusCann. We're pretty downstream.
What a fantastic company.
GLTAH, DYOR
AC8 Price at posting:
26.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.